EP2858998A1 - Monoallyl, monoglycidyl ethers and bisglycidyl ethers of isohexides - Google Patents

Monoallyl, monoglycidyl ethers and bisglycidyl ethers of isohexides

Info

Publication number
EP2858998A1
EP2858998A1 EP13804895.4A EP13804895A EP2858998A1 EP 2858998 A1 EP2858998 A1 EP 2858998A1 EP 13804895 A EP13804895 A EP 13804895A EP 2858998 A1 EP2858998 A1 EP 2858998A1
Authority
EP
European Patent Office
Prior art keywords
isohexide
diallyl
monoallyl
stereoisomer
bisglycidyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP13804895.4A
Other languages
German (de)
French (fr)
Other versions
EP2858998A4 (en
Inventor
Kenneth STENSRUD
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Archer Daniels Midland Co
Original Assignee
Archer Daniels Midland Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Archer Daniels Midland Co filed Critical Archer Daniels Midland Co
Publication of EP2858998A1 publication Critical patent/EP2858998A1/en
Publication of EP2858998A4 publication Critical patent/EP2858998A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Definitions

  • the present invention relates generally to cyclic bifunctional materials such as are used for monomers in polymer synthesis and as intermediates generally, and to the methods by which such materials are made. More particularly, the invention relates to the mono and bisglycidyl ethers of isohexides and their synthesis.
  • Bisglycidyl ethers of dihydric compounds are known in the polymer art, for example, the bisglycidyl ethers of dihydric phenolic
  • the isohexides - isosorbide, isomannide, and isoidide - are bicyclic dihydric compounds having fused tetrahydrofuran rings and cis-bound hydroxyl groups in exo-exo, endo-endo and exo-endo stereoconfigurations, and bisglycidyl ethers of these materials have also been synthesized for use as monomers for making epoxy resins, as well as for inhibiting the growth of certain cancerous cells.
  • the '379 patent does not indicate whether the yields provided by the alternative method were improved compared to the former method, and in fact does not indicate what yields were realized by either method.
  • the examples given would indicate that the overall yields in Leitold et al's process leave considerable room for improvement; thus, for instance, in Example 1a, the yield of 2-allyl isosorbide was calculated at just over 31 % of the theoretical yield.
  • the present invention in a first aspect concerns an improved, high yielding process for making a bisglycidyl ether of an isohexide
  • diallyl isohexide derivative is realized from this method in substantially a quantitative yield.
  • diallyl isohexide is combined with at least two mole equivalents of meta-chloroperbenzoic acid to form the bisglycidyl ether, again preferably being produced in substantially a quantitative yield.
  • the diallyl isohexide is added to the meta-chloroperbenzoic acid in a dropwise or otherwise controlled manner over time.
  • the present invention concerns a process for making either or both of mono and bisglycidyl ethers from a diallyl isohexide, wherein a diallyl isohexide is combined with less than two mole equivalents of meta-chloroperbenzoic acid.
  • the combination is accomplished gradually over time, for example, by adding the diallyl isohexide or isohexides intermediate in a dropwise manner to the meta- chloroperbenzoic acid.
  • the present invention concerns novel monoallyl, monoglycidyl ether derivatives of the isohexides corresponding to the structures shown below:
  • the present invention concerns an improved process for making any of the bisglycidyl ethers of isosorbide, isomannide and isoidide, wherein the yields are dramatically improved compared to the known methods for making these materials.
  • the overall yields from the starting isohexide, or mixture of isohexides if desired are at least 90 percent, more preferably are at least 95 percent and most preferably can be substantially a quantitative yield.
  • diallyl isohexide intermediate (or intermediates for a starting feed of mixed isohexides) is first produced as described in commonly-assigned, copending Patent Cooperation Treaty Application Serial No. PCT/US2013/037168, filed April 18, 2013 and claiming priority from United States Provisional Patent Application Serial No.
  • an isohexide or a mixture of isohexides is reacted in a first step with a Bronsted base whose conjugate acid has an acid dissociation constant pK a greater than 16.
  • the Bronsted base has a pK a of at least 18.
  • the Bronsted base is potassium t-butoxide; t-butanol, the conjugate acid of t-butoxide, has a pK a of about 18.
  • this nucleophilic isohexide anion intermediate is reacted with allyl bromide to form the desired diallyl isohexide or
  • t-butoxide is sterically hindered from appreciably reacting with allyl bromide when the same is subsequently added to the isohexide conjugate base(s)/residual potassium butoxide mixture at the temperatures contemplated for the process and made possible by the selection and use of Bronsted bases such as potassium butoxide whose conjugate acids have higher acid dissociation constants.
  • the isohexide stereoisomer or stereoisomers and the Bransted base are reacted in a nonaqueous solvent system, in the substantial absence of water.
  • a preferred nonaqueous solvent is dimethylformamide.
  • the process is able to be carried out at lower temperatures. For example, in one embodiment, the process is conducted at a reaction temperature of 25 degrees Celsius or less. In another embodiment, the process is conducted at a reaction temperature of 20 degrees Celsius or less.
  • the allyl bromide is added to the conjugate base(s) of the isohexide stereoisomer or stereoisomers gradually over time to reduce the availability of this reagent to react with residual Bronsted base, a less-favored (but still possible) side reaction at these reaction temperatures. In certain embodiments, for example, not more than 13.3% percent allyl bromide is added per minute.
  • diallyl isohexide(s) intermediate as produced by the reaction of an isohexide or mixture of isohexides with the Bronsted base and then by reacting the conjugate base(s) of the isohexide stereoisomer or stereoisomers with allyl bromide as described, is then combined with at least two mole equivalents of meta-chloroperbenzoic acid to form the
  • the combining is accomplished gradually over time given the exothermicity of the epoxidation reaction.
  • the diallyl isohexide synthesis method of the W0'168 Application efficiently separating out and recovering the diallyl isohexide or isohexides (for example, also as described in the WO'168 Application) and then reacting the diallyl isohexide intermediate(s) with meta-chloroperbenzoic acid as described herein and as exemplified below, overall process yields can be substantially quantitative.
  • the isohexide starting material can, as indicated above, be isosorbide, isomannide or isoidide individually or can be a mixture of two or all three of these.
  • Isosorbide is commercially available in industrial and polymer grades, and isomannide is also commercially available. Those skilled in the art will additionally be familiar with methods for making these materials.
  • Isoidide is not presently made and sold on an industrial scale, but methods for making isoidide have been published.
  • an isoidide starting material can be prepared by epimerization from isosorbide.
  • L-iditol is prepared starting from sorbitol.
  • sorbitol is converted by fermentation into L-sorbose, which is subsequently hydrogenated into a mixture of D-sorbitol and L-iditol. This mixture is then converted into a mixture of L-iditol and L-sorbose. After separation from the L-sorbose, the L-iditol can be converted into isoidide.
  • sorbitol is converted into isoidide in a four-step reaction, in a yield of about 50%.
  • the support can vary widely, including silica, alumina, titania, zirconia, and carbon.
  • a carbon support is preferred, inter alia since it can be operated at a wider pH range than other supports.
  • a carbon supported ruthenium catalyst was observed to act more favorably in the epimerization of isosorbide, than other supports, e.g., AI2O3.
  • the catalytically active metal preferably consists essentially of ruthenium, and the support preferably consists essentially of carbon.
  • a suitable ruthenium content is described as from 1 % to 10% by weight of ruthenium, based on the total weight of the catalyst, preferably being about 5% by weight of the catalyst.
  • isosorbide In order to conduct the epimerization, isosorbide is provided in the form of an aqueous solution.
  • concentration of isosorbide therein may widely vary. However, for the sake of process economics as well as results in terms of yield, it is preferred for the isosorbide concentration to be in a range of from 25% by weight to 75% by weight. More preferably, the isosorbide concentration is 30% to 60% by weight. The optimum concentration is believed to approximately 50% by weight.
  • the aqueous solution is subjected to an atmosphere comprising hydrogen.
  • the hydrogen pressure can widely vary, for example, from 20 to 200 bars. However, it was found particularly effective to employ a relatively low pressure in the range of from 20 to 55 bars, and preferably about 40 bars.
  • the catalyst concentration in the reactor calculated as a weight percentage based on the aqueous solution of isosorbide, can range from as low as, e.g., 1 % to as high as, e.g. 50%.
  • a 5% ruthenium catalyst is preferred for a 5% ruthenium catalyst to be employed in a concentration of from 2 to 20%, and more preferably about 4%. It will be understood that these percentages will hold, mutatis mutandis, for other water paste concentrations than 50%, and other catalyst loadings than 5%.
  • Background references in this respect include US 6, 177,598 and US 6,570,043.
  • the ruthenium catalyst as mentioned preferably comprises a carbon support. Different types of carbon support are applicable, e.g.
  • the activated carbon can be, e.g., 50- 70% wetted powder.
  • preferred catalysts include commercial ruthenium on carbon catalysts ex BASF or Evonik (Strem Chemicals).
  • a background reference on Ru/C catalysts is Sifontes Herrera et al, J. Chem Technol Biotechnol (2011), "Sugar hydrogenation over a Ru/C catalyst.”
  • the epimerization reaction is conducted preferably at an elevated temperature, i.e. above 20°C, and preferably below 250°.
  • a preferred temperature range is 200° to 240°, most preferably about 220°C.
  • the duration of the reaction will, as the skilled person knows, generally be shorter at higher temperatures.
  • the residence time in the reactor where the isosorbide solution is subjected to hydrogen under the influence of the catalyst will generally range from 0.1 to 10 hours, preferably. 0.25 to 4 hours, and more preferably 1-2 hours.
  • the isoidide starting material can be recovered by separation methods known to the skilled person, such as by chromatographic techniques, selective crystallization or distillation. The latter can be conducted, e.g. as disclosed by Wright et al. J. Org. Chem., 1964, 29 (10), pp 2979-2982, mentioned above.
  • the present invention concerns a process for making either or both of mono and bisglycidyl ethers from a diallyl isohexide, wherein a diallyl isohexide is combined with less than two mole equivalents of meta-chloroperbenzoic acid.
  • the combination is accomplished gradually over time, for example, by adding the diallyl isohexide or isohexides intermediate in a dropwise manner to the meta- chloroperbenzoic acid.
  • the monoallyl, monoglycidyl ether derivatives may be made selectively in comparison to the bisglycidyl ether derivatives by employing closer to one mole equivalent of the meta-chloroperbenzoic acid, for example, 1.1 to 1.2 mole equivalents of meta-chloroperbenzoic acid, and likewise the relative proportion of monoallyl, monoglycidyl ether product to the bisglycidyl ether product can be established as desired by using a corresponding fraction of mole equivalents between one and two mole equivalents of m-CPBA.
  • a 2-neck, 100 ml_ round-bottomed flask was equipped with an argon line and a septum, then charged with 2.28 g of meta-chloroperbenzoic acid (mCPBA, 10.2 mmol) and 20 mL of methylene chloride, then cooled to about 0 degrees Celsius in an ice/saline bath.
  • mCPBA meta-chloroperbenzoic acid
  • a separate 50 mL round bottomed flask was charged with 1.00 g of diallylisoidide (4.4 mmol) and 20 mL of methylene chloride, then, upon complete dissolution of the
  • diallylisoidide the solution was pulled into a 25 cc syringe and added dropwise to the mCPBA solution through the septum of the 2-neck flask, while maintaining 0 deg. C and an argon atmosphere. After being added gradually over a span of about 10 minutes, the solution was allowed to warm to room temperature and the reaction continued for 20 hours. After this time, the solution is observed to contain a profusion of white solid. This solid material was removed through a bed of Celite® diatomaceous earth (about 10 grams), the mother liquor filtrate was then cooled to 0 degrees Celsius in a saline bath.
  • DMF dimethylformamide
  • This heterogeneous mixture was stirred for 30 minutes at room temperature, then brought to about 0 degrees Celsius in an ice/saturated brine bath. While stirring and under argon, 3.90 mL of allyl bromide (45.2 mmol) was added dropwise via syringe. After addition was complete, the ice bath was removed and the solution warmed to room temperature. The reaction was continued for 4 hours at room temperature under argon. After this time, the heterogeneous solution was filtered to remove potassium bromide and other solids.
  • DMF dimethylformamide
  • the heterogeneous solution was filtered to remove potassium bromide and other solids.
  • the filtrate was then transferred to a 250 mL boiling flask containing a Teflon stir bar, diluted with 50 mL of methylene chloride and 50 mL of water, and vigorously stirred.
  • the biphasic solution was poured into a 250 mL separatory funnel and the bottom organic layer removed into a 125 mL Erlenmeyer flask. This solution was then diluted with another 50 mL volume of water.
  • the resultant biphasic solution was mixed as before, and the organic phase was extracted, dried with anhydrous magnesium sulfate and concentrated in vacuo, producing a light yellow oil, 1.42 (91 %).
  • a two neck, boiling flask equipped with a Teflon stir bar was charged with 1.56 g of 77% meta-chloroperbenzoic acid (mCPBA, 6.97 mmol) and 20 mL of methylene chloride. After complete dissolution, the flask was outfitted with a rubber septum and argon line, and immersed in an ice/brine bath at about 0 degrees Celsius. While stirring under argon and low- temperature maintenance, 900 mg of diallyl isomannide, previously diluted with 10 mL of methylene chloride, was injected dropwise through the septum via a syringe. Once completely added, the ice bath was removed and the reaction proceeded overnight at room temperature.
  • mCPBA meta-chloroperbenzoic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

An improved, high yielding process is disclosed for making bisglycidyl ether derivatives of isosorbide, isomannide and/or isoidide, wherein up to quantitative yields overall are demonstrated. In another related aspect, a process is disclosed for making novel monoallyl, monoglycidyl ether derivatives or a combination of monoallyl, monoglycidyl ether derivatives and bisglycidyl ether derivatives via the same diallyl isohexide intermediate.

Description

MONOALLYL, MONOGLYCIDYL ETHERS AND BISGLYCIDYL ETHERS OF
ISOHEXIDES
[0001] The present invention relates generally to cyclic bifunctional materials such as are used for monomers in polymer synthesis and as intermediates generally, and to the methods by which such materials are made. More particularly, the invention relates to the mono and bisglycidyl ethers of isohexides and their synthesis.
[0002] Bisglycidyl ethers of dihydric compounds are known in the polymer art, for example, the bisglycidyl ethers of dihydric phenolic
compounds and of aliphatic glycols containing two primary hydroxyl groups are used in preparing epoxy resins. The isohexides - isosorbide, isomannide, and isoidide - are bicyclic dihydric compounds having fused tetrahydrofuran rings and cis-bound hydroxyl groups in exo-exo, endo-endo and exo-endo stereoconfigurations, and bisglycidyl ethers of these materials have also been synthesized for use as monomers for making epoxy resins, as well as for inhibiting the growth of certain cancerous cells.
[0003] In US 3,272,845 to Zech at al., for example, the bisglycidyl ethers of isosorbide, isomannide and isoidide are indicated as having been made by forming a solution of a salt of the particular isohexide by reaction with an alkali metal hydride, then reacting the formed solution with a
stoichiometric excess of epichlorohydrin, and recovering the formed
bisglycidyl ether from the reaction mixture, col. 1 , lines 53-59. Yields, however, were low: 17.6% of theoretical for isosorbide bisglycidyl ether;
14.6% for isomannide bisglycidyl ether; and 16.2% for isoidide bisglycidyl ether. Additionally, Zech at al. reported that their process was developed after conventional methods of forming the glycidyl ethers of hydroxyl compounds - by reaction with epichlorohydrin followed by
dehydrohalogenation and by epoxidizing the diallyl ethers of the isohexides with aqueous peracetic acid - had "failed" to produce the desired bisglycidyl ether products.
[0004] More recently, in US 4,769,379 to Leitold et al., the monoglycidyl ethers of the isohexides were reported as being made through epoxidizing, for example, 2-allylisosorbide (Examples 1 b, 10b, 13b) or 5-allylisosorbide (Example 5b). In similar manner, monoglycidyl ethers were also made from derivatives of the isohexides via corresponding allyl compounds such as those listed, for example, at column 8, lines 38-57. Bisglycidyl ethers were also made in Example 7 from isosorbide and in Example 12 from isomannide, via the same method used by Zech et al. but also via a different method, wherein a diallyl isosorbide and diallyl isomannide were respectively reacted with 3-chloroperbenzoic acid (alternatively found in the literature as meta- chloroperbenzoic acid).
[0005] The '379 patent does not indicate whether the yields provided by the alternative method were improved compared to the former method, and in fact does not indicate what yields were realized by either method. However, in the context of a process for manufacturing the bisglycidyl ethers from an isohexide by means of an allyl or diallyl isohexide intermediate, the examples given would indicate that the overall yields in Leitold et al's process leave considerable room for improvement; thus, for instance, in Example 1a, the yield of 2-allyl isosorbide was calculated at just over 31 % of the theoretical yield.
SUMMARY OF THE INVENTION
[0006] The present invention in a first aspect concerns an improved, high yielding process for making a bisglycidyl ether of an isohexide
(isosorbide, isomannide or isoidide) via a diallyl isohexide intermediate, wherein an isohexide stereoisomer is reacted with a Bransted base whose conjugate acid has an acid dissociation constant pKa greater than 16 to form a conjugate base of the isohexide stereoisomer, then the conjugate base of the isohexide stereoisomer is reacted with allyl bromide to form the diallyl isohexide derivative. Preferably the diallyl isohexide derivative is realized from this method in substantially a quantitative yield. The diallyl isohexide is combined with at least two mole equivalents of meta-chloroperbenzoic acid to form the bisglycidyl ether, again preferably being produced in substantially a quantitative yield. In a preferred embodiment, the diallyl isohexide is added to the meta-chloroperbenzoic acid in a dropwise or otherwise controlled manner over time.
[0007] In a second aspect, the present invention concerns a process for making either or both of mono and bisglycidyl ethers from a diallyl isohexide, wherein a diallyl isohexide is combined with less than two mole equivalents of meta-chloroperbenzoic acid. In a preferred embodiment, the combination is accomplished gradually over time, for example, by adding the diallyl isohexide or isohexides intermediate in a dropwise manner to the meta- chloroperbenzoic acid.
[0008] In a third aspect, the present invention concerns novel monoallyl, monoglycidyl ether derivatives of the isohexides corresponding to the structures shown below:
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
[0009] In a first aspect as just mentioned, the present invention concerns an improved process for making any of the bisglycidyl ethers of isosorbide, isomannide and isoidide, wherein the yields are dramatically improved compared to the known methods for making these materials.
Preferably, the overall yields from the starting isohexide, or mixture of isohexides if desired, are at least 90 percent, more preferably are at least 95 percent and most preferably can be substantially a quantitative yield.
[0010] In this first aspect, the diallyl isohexide intermediate (or intermediates for a starting feed of mixed isohexides) is first produced as described in commonly-assigned, copending Patent Cooperation Treaty Application Serial No. PCT/US2013/037168, filed April 18, 2013 and claiming priority from United States Provisional Patent Application Serial No.
61/658,1 18, filed June 11 , 2012, for "Diallyl Ethers of Anhydrohexitols and Processes for Making the Same" (hereafter, "the W0'168 Application").
[0011] In the W0'168 Application, an isohexide or a mixture of isohexides is reacted in a first step with a Bronsted base whose conjugate acid has an acid dissociation constant pKa greater than 16. Preferably, the Bronsted base has a pKa of at least 18. In one embodiment, the Bronsted base is potassium t-butoxide; t-butanol, the conjugate acid of t-butoxide, has a pKa of about 18.
[0012] By using a Bronsted base whose conjugate acid has an acid dissociation constant pKa greater than 16, for example, a Bronsted base such as potassium t-butoxide, formation of the nucleophilic isohexide anion intermediate (the isoidide intermediate is shown) is thermodynamically favored:
[0013] In a second step, this nucleophilic isohexide anion intermediate is reacted with allyl bromide to form the desired diallyl isohexide or
isohexides. In this step, t-butoxide is sterically hindered from appreciably reacting with allyl bromide when the same is subsequently added to the isohexide conjugate base(s)/residual potassium butoxide mixture at the temperatures contemplated for the process and made possible by the selection and use of Bronsted bases such as potassium butoxide whose conjugate acids have higher acid dissociation constants.
[0014] In a preferred embodiment, the isohexide stereoisomer or stereoisomers and the Bransted base are reacted in a nonaqueous solvent system, in the substantial absence of water. A preferred nonaqueous solvent is dimethylformamide. [0015] As an additional preferred feature, owing to the ready formation of the conjugate base(s) of the isohexide in the initial combination of the Br0nsted base(s) with the isohexide(s), the process is able to be carried out at lower temperatures. For example, in one embodiment, the process is conducted at a reaction temperature of 25 degrees Celsius or less. In another embodiment, the process is conducted at a reaction temperature of 20 degrees Celsius or less. While t-butoxide as noted above is sterically hindered from reacting with the allyl bromide, nevertheless as an additional safeguard against an unwanted side reaction, by carrying out the diallyl isohexide synthesis at lower temperatures the activation barrier to reaction of t-butoxide with allyl bromide will be correspondingly less likely to be
surmounted.
[0016] In other embodiments, the allyl bromide is added to the conjugate base(s) of the isohexide stereoisomer or stereoisomers gradually over time to reduce the availability of this reagent to react with residual Bronsted base, a less-favored (but still possible) side reaction at these reaction temperatures. In certain embodiments, for example, not more than 13.3% percent allyl bromide is added per minute.
[0017] The diallyl isohexide(s) intermediate, as produced by the reaction of an isohexide or mixture of isohexides with the Bronsted base and then by reacting the conjugate base(s) of the isohexide stereoisomer or stereoisomers with allyl bromide as described, is then combined with at least two mole equivalents of meta-chloroperbenzoic acid to form the
corresponding bisglycidyl ether or ethers. In preferred embodiments, the combining is accomplished gradually over time given the exothermicity of the epoxidation reaction. Generally, by employing the diallyl isohexide synthesis method of the W0'168 Application, efficiently separating out and recovering the diallyl isohexide or isohexides (for example, also as described in the WO'168 Application) and then reacting the diallyl isohexide intermediate(s) with meta-chloroperbenzoic acid as described herein and as exemplified below, overall process yields can be substantially quantitative.
[0018] The isohexide starting material can, as indicated above, be isosorbide, isomannide or isoidide individually or can be a mixture of two or all three of these. Isosorbide is commercially available in industrial and polymer grades, and isomannide is also commercially available. Those skilled in the art will additionally be familiar with methods for making these materials.
[0019] Isoidide is not presently made and sold on an industrial scale, but methods for making isoidide have been published. For example, in one embodiment, an isoidide starting material can be prepared by epimerization from isosorbide.
[0020] In L. W. Wright, J. D. Brandner, J. Org. Chem., 1964, 29 (10), pp 2979-2982, such epimerization is induced by means of Ni catalysis, using nickel supported on diatomaceous earth. The reaction is conducted under relatively severe conditions, such as a temperature of 220°C to 240 °C at a pressure of 150 atmosphere. The reaction reaches a steady state after two hours, with an equilibrium mixture containing isoidide (57%), isosorbide (36%) and isomannide (7%). Comparable results were obtained when starting from isoidide or isomannide. Increasing the pH to 10-1 1 was found to have an accelerating effect, as well as increasing the temperature and nickel catalyst concentration. A similar disclosure is to be found in US Patent No. 3,023,223.
[0021] In EP 1 647 540, L-iditol is prepared starting from sorbitol. In a first step sorbitol is converted by fermentation into L-sorbose, which is subsequently hydrogenated into a mixture of D-sorbitol and L-iditol. This mixture is then converted into a mixture of L-iditol and L-sorbose. After separation from the L-sorbose, the L-iditol can be converted into isoidide. Thus, sorbitol is converted into isoidide in a four-step reaction, in a yield of about 50%.
[0022]A preferred method for preparing isoidide by the epimerization of isosorbide is described in European Patent Application No. 12156170.8, "Method of Making Isoidide", filed Feb. 20, 2012, wherein a supported ruthenium catalyst is used at a starting pH of above 7, preferably of from 8 to 10, with the starting pH referring to the pH of the aqueous solution of isosorbide.
[0023] The epimerization of isosorbide into isoidide is conducted according to this process under relatively mild conditions, such that an equilibrium production of isoidide can be attained while avoiding mass losses through hydrodeoxygenation and providing a better overall yield compared to the results of Wright and Brandner.
[0024] The support can vary widely, including silica, alumina, titania, zirconia, and carbon. A carbon support is preferred, inter alia since it can be operated at a wider pH range than other supports. As well, a carbon supported ruthenium catalyst was observed to act more favorably in the epimerization of isosorbide, than other supports, e.g., AI2O3. The catalytically active metal preferably consists essentially of ruthenium, and the support preferably consists essentially of carbon. A suitable ruthenium content is described as from 1 % to 10% by weight of ruthenium, based on the total weight of the catalyst, preferably being about 5% by weight of the catalyst.
[0025] In order to conduct the epimerization, isosorbide is provided in the form of an aqueous solution. The concentration of isosorbide therein may widely vary. However, for the sake of process economics as well as results in terms of yield, it is preferred for the isosorbide concentration to be in a range of from 25% by weight to 75% by weight. More preferably, the isosorbide concentration is 30% to 60% by weight. The optimum concentration is believed to approximately 50% by weight.
[0026] The aqueous solution is subjected to an atmosphere comprising hydrogen. The hydrogen pressure can widely vary, for example, from 20 to 200 bars. However, it was found particularly effective to employ a relatively low pressure in the range of from 20 to 55 bars, and preferably about 40 bars.
[0027] Calculated on the basis of a water paste comprising 50% of a 5% ruthenium on carbon catalyst, the catalyst concentration in the reactor, calculated as a weight percentage based on the aqueous solution of isosorbide, can range from as low as, e.g., 1 % to as high as, e.g. 50%.
However, for the sake of process economics as well as results in terms of yield and specificity, it is preferred for a 5% ruthenium catalyst to be employed in a concentration of from 2 to 20%, and more preferably about 4%. It will be understood that these percentages will hold, mutatis mutandis, for other water paste concentrations than 50%, and other catalyst loadings than 5%. [0028] The skilled person will be aware of how to generally conduct the ruthenium catalyzed reaction. Background references in this respect include US 6, 177,598 and US 6,570,043.
[0029] The ruthenium catalyst as mentioned preferably comprises a carbon support. Different types of carbon support are applicable, e.g.
activated carbon or carbon nanotubes. The activated carbon can be, e.g., 50- 70% wetted powder. Typically preferred catalysts include commercial ruthenium on carbon catalysts ex BASF or Evonik (Strem Chemicals). A background reference on Ru/C catalysts is Sifontes Herrera et al, J. Chem Technol Biotechnol (2011), "Sugar hydrogenation over a Ru/C catalyst."
[0030] The epimerization reaction is conducted preferably at an elevated temperature, i.e. above 20°C, and preferably below 250°. A preferred temperature range is 200° to 240°, most preferably about 220°C. The duration of the reaction will, as the skilled person knows, generally be shorter at higher temperatures. The residence time in the reactor where the isosorbide solution is subjected to hydrogen under the influence of the catalyst, will generally range from 0.1 to 10 hours, preferably. 0.25 to 4 hours, and more preferably 1-2 hours.
[0031] It is preferred to adjust the pH of the aqueous solution of isosorbide. Although, for the sake of conducting the epimerization per se, the pH may widely vary, it has been found that unwanted side reactions, which lead to loss of matter as a result of the formation of volatiles, can be reduced considerably by adjusting the pH to a value of 8 to 10.
[0032] From the equilibrium mixture, the isoidide starting material can be recovered by separation methods known to the skilled person, such as by chromatographic techniques, selective crystallization or distillation. The latter can be conducted, e.g. as disclosed by Wright et al. J. Org. Chem., 1964, 29 (10), pp 2979-2982, mentioned above. Other references descriptive of methods for separating an epimerization mixture of isosorbide, isomannide and isoidide include commonly-assigned US 7,439,352 and US 6,849,748 to Moore et al, both of which are hereby incorporated herein by reference, as well as US 6,670,033 to Hubbard et al., US 4,564,692 to Feldman et al., US 7,122,661 to Fleche at al. and US 8,008,477 to Fuertes. [0033] In a second aspect, the present invention concerns a process for making either or both of mono and bisglycidyl ethers from a diallyl isohexide, wherein a diallyl isohexide is combined with less than two mole equivalents of meta-chloroperbenzoic acid. In a preferred embodiment, the combination is accomplished gradually over time, for example, by adding the diallyl isohexide or isohexides intermediate in a dropwise manner to the meta- chloroperbenzoic acid.
[0034]We have found in this regard that by using less than the two mole equivalents of the meta-chloroperbenzoic acid required to fully oxidize the allyl moieties on the diallyl isohexide(s), novel monoallyl, monoglycidyl ether derivatives of isosorbide, isomannide and isoidide may be made:
Isosorbide monoallyl, monoglycidyl ether isomers
Isomannide monoallyl, monoglycidyl ether Isoidide monoallyl, monoglycidyl ether
[0035] Because the double bonds of the allyl moieties are well removed from the bisfuran ring system characteristic of each of the isohexides, it would be expected that any given allyl moiety of a particular diallyl isohexide will oxidize no more or less readily than the other allyl moiety, so that the full spectrum of monoallyl, monoglycidyl ether materials should be possible. As well, the monoallyl, monoglycidyl ether derivatives may be made selectively in comparison to the bisglycidyl ether derivatives by employing closer to one mole equivalent of the meta-chloroperbenzoic acid, for example, 1.1 to 1.2 mole equivalents of meta-chloroperbenzoic acid, and likewise the relative proportion of monoallyl, monoglycidyl ether product to the bisglycidyl ether product can be established as desired by using a corresponding fraction of mole equivalents between one and two mole equivalents of m-CPBA.
[0036] Further, by using diallyl isohexide synthesis of the WO'168 Application, quantitative yields of the monoallyl, monoglycidyl ether isohexide derivatives, of the bisglycidyl ether isohexide derivatives or of a desired combination of the monoallyl, monoglycidyl ether and bisglycidyl ether derivatives can be achieved through using a corresponding fraction of mole equivalents between one and two mole equivalents of m-CPBA and carrying out the process otherwise as described above.
[0037] The present invention is further illustrated by the following examples: Γ0038Ί Example 1
[0039] A 2-neck, 100 ml_ round-bottomed flask was equipped with an argon line and a septum, then charged with 2.28 g of meta-chloroperbenzoic acid (mCPBA, 10.2 mmol) and 20 mL of methylene chloride, then cooled to about 0 degrees Celsius in an ice/saline bath. A separate 50 mL round bottomed flask was charged with 1.00 g of diallylisoidide (4.4 mmol) and 20 mL of methylene chloride, then, upon complete dissolution of the
diallylisoidide, the solution was pulled into a 25 cc syringe and added dropwise to the mCPBA solution through the septum of the 2-neck flask, while maintaining 0 deg. C and an argon atmosphere. After being added gradually over a span of about 10 minutes, the solution was allowed to warm to room temperature and the reaction continued for 20 hours. After this time, the solution is observed to contain a profusion of white solid. This solid material was removed through a bed of Celite® diatomaceous earth (about 10 grams), the mother liquor filtrate was then cooled to 0 degrees Celsius in a saline bath. Two successive 50 mL volumes of 10% sodium bisulfate solution were added to remove excess mCPBA, with each step entailing extraction of the bottom, organic phase. The organic phase was then subjected to two successive 50 mL volumes of concentrated sodium bicarbonate, with extraction of the organic phase after each addition. The treated mother liquor was dried with anhydrous magnesium sulfate, then concentrated in vacuo, producing a light yellow, loose oil (1.07 g, 94%, diastereomers).
Spectroscopic validation: 1 H NMR (CDCI3, 400 MHz), δ (ppm) 4.60 (d, J = 6.2 Hz, 2H), 4.00 (s, 2H), 3.86-3.80 (m, 4H), 3.43-3.41 (m, 4H), 3.12 (dd, J = 5.0, J = 1.6 Hz, 2H), 2.78 (d, J = 4.8 Hz, 2H), 2.59 (d, J = 4.2 Hz, 2H); 3C (CDCI3, 100 MHz), δ (ppm) 85.59, 84.25, 72.49, 70.46, 53.63, 50.83, 44.56; HRMS (GC-TOF): Calculated for C12H1806 (m/z), 258.2677. Found (m/z): 258.2691. (Calculated yield furnished above (1.07 g, 94%); Theoretical Yield: 1.1 1g bis(all
Γ0040Ί Example 2
[0041]An oven dried, two neck round bottomed flask equipped with a Teflon magnetic stir bar was charged with 3.00 g of isoidide (20.5 mmol), 5.30 g potassium t-butoxide (47.2 mmol), and 50 mL of anhydrous
dimethylformamide (DMF). This heterogeneous mixture was stirred for 30 minutes at room temperature, then brought to about 0 degrees Celsius in an ice/saturated brine bath. While stirring and under argon, 3.90 mL of allyl bromide (45.2 mmol) was added dropwise via syringe. After addition was complete, the ice bath was removed and the solution warmed to room temperature. The reaction was continued for 4 hours at room temperature under argon. After this time, the heterogeneous solution was filtered to remove potassium bromide and other solids. The filtrate was then transferred to a 250 mL boiling flask containing a Teflon stir bar, was diluted with 50 mL of methylene chloride and 50 mL of water, and vigorously stirred. The biphasic solution was poured into a 250 mL separatory funnel and the bottom organic layer removed into a 125 mL Erlenmeyer flask. This solution was then diluted with another 50 mL volume of water, and the resultant biphasic solution mixed as before. The organic phase was extracted, dried with anhydrous magnesium sulfate and concentrated in vacuo, producing a light yellow oil, 4.46 g (96% yield). GC/MS (El), one signal m/z 226.1. This corresponds to (3S,3aR,6S,6aR)-3,6-bis(allyloxy)hexahydrofuro[3,2-b]furan (compound B, diallyl isoidide).
B
[0042] Subsequently, a separate two neck, boiling flask equipped with a Teflon stir bar was charged with 5.44 g of 77% meta-chloroperbenzoic acid (mCPBA, 24.3 mmol) and 30 mL of methylene chloride. After complete dissolution of the mCPBA, the flask was outfitted with a rubber septum and argon line, and immersed in an ice/brine bath at about 0 degrees Celsius. While stirring, under argon, and low-temperature maintenance, 4.40 g (19.4 mmol) of diallyl isoidide (B), previously diluted with 10 mL of methylene chloride, was injected dropwise through the septum via a syringe. Once the diallyl isoidide was completely added, the ice bath was removed and the reaction continued overnight at room temperature. After this time, profuse precipitate was observed and filtered, and the mother liquor was diluted with 50 mL of saturated sodium metabisulfite. This biphasic solution was stirred for 10 minutes, and the organic layer was extracted, then diluted with a saturated solution of sodium bicarbonate. Substantial effervescence was observed (indicating carbon dioxide evolution). The organic layer was then removed, dried with anhydrous magnesium sulfate, and evaporated to dryness, resulting in a light yellow oil, (4.87 g). TLC (2:1 hexanes/ethyl acetate, cerium molybdate stain) manifested three spots, rf1 (B) 0.57, rf2 (D) 0.46, rf3 (C) 0.33. The patent difference in rf would allow facile isolation of B, C and D by silica gel flash chromatography, for example. GC/MS (El, M+) manifested three signals with m/z consistent with diallyl isoidide (B, 226.1), (3S,3aR,6S,6aR)-3-(allyloxy)-6-(oxiran-2-ylmethoxy)hexahydrofuro[3,2- b]furan (D, 242.0) and (3S,3aR,6S,6aR)-3,6-bis(oxiran-2- ylmethoxy)hexahydrofuro[3,2-b]furan (C, 258.1). The corresponding integration of the signals suggests an approximate 0.5:1 :0.5 molar ratio of B:D:C in the product mixture.
B C D
Γ0043Ί Example 3
[0044]An oven dried, two neck round bottomed flask equipped with a Teflon magnetic stir bar was charged with 3.00 g of isosorbide (20.5 mmol), 5.30 g potassium t-butoxide (47.2 mmol), and 50 mL of anhydrous DMF. This heterogeneous mixture was stirred for 30 minutes at room temperature, then brought to about 0 degrees Celsius in an ice/saturated brine bath. While stirring and under argon, 3.90 mL of allyl bromide (45.2 mmol) was added dropwise via syringe. After addition was complete, the ice bath was removed and the solution warmed to room temperature. The reaction was continued for 4 hours at room temperature under argon. After this time, the
heterogeneous solution was filtered to remove potassium bromide and other solids. The filtrate was then transferred to a 250 mL boiling flask containing a Teflon stir bar, was diluted with 50 mL of methylene chloride and 50 mL of water, and vigorously stirred. The biphasic solution was poured into a 250 mL separatory funnel and the bottom organic layer removed into a 125 mL
Erlenmeyer flask. This solution was then diluted with another 50 mL volume of water, the resultant biphasic solution mixed as before, and the organic phase was extracted, dried with anhydrous magnesium sulfate and
concentrated in vacuo, producing a light yellow oil, 4.12 g (89%). This material was spectroscopically confirmed by GC/MS (El), providing one signal (m/z 226.1) corresponding to (3R,3aR,6S,6aR)-3,6- bis(allyloxy)hexahydrofuro[3,2-b]furan (diallyl isosorbide, B).
B
[0045] Subsequently, a separate two neck, boiling flask equipped with a Teflon stir bar was charged with 4.34 g of 77% meta-chloroperbenzoic acid (mCPBA, 19.4 mmol) and 30 mL of methylene chloride. After complete dissolution, the flask was outfitted with a rubber septum and argon line, and immersed in an ice/brine bath (about 0 degrees C). While stirring, under argon, and low-temperature maintenance, 3.51 g (15.5 mmol) of diallyl isosorbide, previously diluted with 10 mL of methylene chloride, was injected dropwise through the septum via a syringe. Once completely added, the ice bath was removed and the reaction proceeded overnight at room
temperature. After this time, profuse precipitate was observed and filtered, and the mother liquor was diluted with 50 mL of saturated sodium
metabisulfite. This biphasic solution was stirred for 10 minutes, and the organic layer extracted, then diluted with a saturated solution of sodium bicarbonate. Substantial effervescence was observed (indicating CO2 evolution). The organic layer was then removed, dried with anhydrous magnesium sulfate, and evaporated to dryness, resulting in a light yellow oil, (3.66 g). TLC (2:1 Hexanes/Ethyl Acetate, cerium molybdate stain) manifested three spots, rfl (B) 0.61 , rf2 (D) 0.49, rf3 (C) 0.37. The patent difference in rf would allow facile isolation of B, C and D by silica gel flash chromatography, for example. Spectroscopic analysis by GC/MS (El, M+) manifested four signals with m/z consistent with the diallyl isosorbide (226.1), (3R,3aR,6S,6aR)-3-(allyloxy)-6-(oxiran-2-ylmethoxy)hexahydrofuro[3,2- bjfuran (compound D, 242.0) and 3R,3aR,6S,6aR)-3,6-bis(oxiran-2- ylmethoxy)hexahydrofuro[3,2-b]furan (compound C, 258.1). The corresponding integration of the signals suggests an approximate 0.5:1 :0.5 molar ratio of B:D:C in the product mixture.
B C D
+ Isomer
Γ00461 Example 4
[0047]An oven dried, two neck round bottomed flask equipped with a Teflon magnetic stir bar was charged with 1.00 g of isomannide (6.84 mmol), 1.69 g potassium f-butoxide (15.1 mmol), and 25 mL of anhydrous DMF. This heterogeneous mixture was stirred for 30 minutes at room temperature, then brought to about 0°C in an ice/saturated brine bath. While stirring and under argon, 1.30 mL of allyl bromide (15.1 mmol) was added dropwise via syringe. After addition was complete, the ice bath was removed and the solution warmed to room temperature. The reaction continued overnight at room temperature under argon. After this time, the heterogeneous solution was filtered to remove potassium bromide and other solids. The filtrate was then transferred to a 250 mL boiling flask containing a Teflon stir bar, diluted with 50 mL of methylene chloride and 50 mL of water, and vigorously stirred. The biphasic solution was poured into a 250 mL separatory funnel and the bottom organic layer removed into a 125 mL Erlenmeyer flask. This solution was then diluted with another 50 mL volume of water. The resultant biphasic solution was mixed as before, and the organic phase was extracted, dried with anhydrous magnesium sulfate and concentrated in vacuo, producing a light yellow oil, 1.42 (91 %). Spectroscopic analysis confirmed diallyl isomannide: 1 H NMR (400 MHz, CDCI3) d (ppm) 5.93-5.91 (m, 2H), 5.27 (d, J = 8.2 Hz, 2H), 5.19 (d, J = 8.0 Hz, 2H), 4.52 (s, 2H), 4.13 (dd, J = 6.2 Hz, J = 1.8 Hz, 2H), 4.1 (m, 4H), 3.88 (d, J = 7.2 Hz, 2H), 3.70 (d, J = 7.0 Hz, 2H); 13C NMR (125 MHz, CDCI3) d (ppm) 134.73, 117.98, 80.63, 79.89, 71.92, 71.26; GC/MS (El) one signal m/z 226.1 , corresponds to diallyl isomannide
((3R,3aR,6R,6aR)-3,6-bis(allyloxy)hexahydrofuro[3,2-b]furan, compound B).
B
[0048] Separately, a two neck, boiling flask equipped with a Teflon stir bar was charged with 1.56 g of 77% meta-chloroperbenzoic acid (mCPBA, 6.97 mmol) and 20 mL of methylene chloride. After complete dissolution, the flask was outfitted with a rubber septum and argon line, and immersed in an ice/brine bath at about 0 degrees Celsius. While stirring under argon and low- temperature maintenance, 900 mg of diallyl isomannide, previously diluted with 10 mL of methylene chloride, was injected dropwise through the septum via a syringe. Once completely added, the ice bath was removed and the reaction proceeded overnight at room temperature. After this time, profuse precipitate was observed. The precipitate was filtered, and the mother liquor diluted with 50 mL of saturated sodium metabisulfite. This biphasic solution was stirred for 10 minutes, and the organic layer was extracted then diluted with a saturated solution of sodium bicarbonate. Substantial effervescence was observed (indicating CO2 evolution). The organic layer was then removed, dried with anhydrous magnesium sulfate, and evaporated to dryness, resulting in a light yellow oil, (947 mg). TLC (2:1 Hexanes/Ethyl Acetate, cerium molybdate stain) manifested two spots only, rf1 (D) 0.52, rf2 (C) 0.32. The sizeable disparity in rf values would permit facile sequestration of C and D by silica gel flash chromatography, for example. GC/MS (El, M+) manifested two signals with m/z consistent with (3R,3aR,6R,6aR)-3,6- bis(oxiran-2-ylmethoxy)hexahydrofuro[3,2-b]furan, compound C (242.0) and with (3R,3aR,6R,6aR)-3-(allyloxy)-6-(oxiran-2-ylmethoxy)hexahydrofuro[3,2- b]furan, compound D (258.1). The corresponding integration of the signals suggests an approximate 3:1 molar ratio of C to D in the product mixture. 1 H NMR (400 MHz, CDCI3) revealed signals that accorded to C and D only; peak integration was congruent to GC/MS in suggesting a 3:1 molar ratio of C to D in the mixture.

Claims

A process for making a bisglycidyl ether of an isohexide at an overall yield of at least 90 percent based on the amount of the starting isohexide, comprising the steps of
forming a diallyl isohexide intermediate, by a process including reacting an isohexide stereoisomer with a Bronsted base whose conjugate acid has an acid dissociation constant pKa greater than 16 to form a conjugate base of the isohexide stereoisomer, then reacting the conjugate base of the isohexide stereoisomer with allyl bromide to form the diallyl isohexide intermediate in substantially a quantitative yield; and
reacting the diallyl isohexide intermediate with at least two mole equivalents of meta-chloroperbenzoic acid.
A process as in Claim 1 , wherein the bisglycidyl ether of isohexide is produced at an overall yield of at least 95 percent based on the amount of the starting isohexide.
A process as in Claim 1 , wherein the bisglycidyl ether of isohexide is produced in substantially a quantitative yield.
A process as in any of Claims 1-3, wherein the Bronsted base has a pKa of at least 18.
A process as in Claim 4, wherein the Bronsted base is potassium t- butoxide.
A process as in any of Claims 1-5, wherein the isohexide stereoisomer and Bronsted base are reacted in a nonaqueous solvent system, in the substantial absence of water.
A process as in any of Claims 1-6, wherein the reaction temperature is 25 degrees Celsius or less.
8. A process as in any of Claims 1-7, wherein the reaction temperature is 20 degrees Celsius or less.
9. A process as in any of Claims 1-8, wherein allyl bromide is added to the conjugate base of isohexide stereoisomer gradually over time.
10. A process as in Claim 9, wherein not more than 13.3 percent of allyl
bromide is added to the conjugate base of isohexide stereoisomer per minute.
1 . A process as in any of Claims 1-10, wherein a mixture of two or more isohexide stereoisomers are reacted with the Bronsted base.
12. A process for making a monoallyl, monoglycidyl ether derivative of an isohexide, comprising reacting a diallyl isohexide derivative with less than two mole equivalents of meta-chloroperbenzoic acid.
13. A process as in Claim 12, wherein both of monoallyl, monoglycidyl ether and bisglycidyl ether derivatives of an isohexide are produced, by reacting a diallyl isohexide derivative with less than two mole equivalents but more than one mole equivalent of meta-chlorobenzoic acid.
14. A monoallyl, monoglycidyl ether derivative of isosorbide .
15. A monoallyl, monoglycidyl ether derivative of isomannide .
16. A monoallyl, monoglycidyl ether derivative of isoidide.
EP13804895.4A 2012-06-11 2013-06-10 Monoallyl, monoglycidyl ethers and bisglycidyl ethers of isohexides Withdrawn EP2858998A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261658118P 2012-06-11 2012-06-11
US201261669728P 2012-07-10 2012-07-10
PCT/US2013/044878 WO2013188253A1 (en) 2012-06-11 2013-06-10 Monoallyl, monoglycidyl ethers and bisglycidyl ethers of isohexides

Publications (2)

Publication Number Publication Date
EP2858998A1 true EP2858998A1 (en) 2015-04-15
EP2858998A4 EP2858998A4 (en) 2016-01-13

Family

ID=49758637

Family Applications (1)

Application Number Title Priority Date Filing Date
EP13804895.4A Withdrawn EP2858998A4 (en) 2012-06-11 2013-06-10 Monoallyl, monoglycidyl ethers and bisglycidyl ethers of isohexides

Country Status (3)

Country Link
US (1) US9290509B2 (en)
EP (1) EP2858998A4 (en)
WO (1) WO2013188253A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170355658A1 (en) * 2014-12-18 2017-12-14 Archer Daniels Midland Company Co2-mediated etherification of bio-based diols
FR3040059B1 (en) 2015-08-13 2019-05-17 Roquette Freres USE OF A LOW VISCOSITY BIS-ANHYDROHEXITOL ETHERS COMPOSITION AS A REACTIVE DILUENT FOR CROSS-LINKABLE COMPOSITIONS OF RESINS, ADHESIVES, COATINGS AND COMPOSITE MATRIXES

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769379A (en) * 1984-06-06 1988-09-06 Heinrich Mack Nachf. Dianhydrohexite derivatives, and their use as pharmaceuticals

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080021209A1 (en) * 2006-06-01 2008-01-24 New Jersey Institute Of Technology Ethers of bisanhydrohexitols
US7619056B2 (en) * 2006-06-02 2009-11-17 New Jersey Institute Of Technology Thermoset epoxy polymers from renewable resources
JP2011213716A (en) * 2010-03-15 2011-10-27 Mitsubishi Chemicals Corp Method for producing polyallyloxy compound and method for producing polyglycidyloxy compound

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769379A (en) * 1984-06-06 1988-09-06 Heinrich Mack Nachf. Dianhydrohexite derivatives, and their use as pharmaceuticals

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
LANGHALS E ET AL: "ALKYLATION OF KETONES BY USE OF SOLID KOH IN DIMETHYL SULFOXIDE", TETRAHEDRON LETTERS, vol. 31, no. 6, 1990, PERGAMON, GB, pages 859 - 862, XP000101060, ISSN: 0040-4039, DOI: 10.1016/S0040-4039(00)94647-1 *
None *
See also references of WO2013188253A1 *

Also Published As

Publication number Publication date
US20150141672A1 (en) 2015-05-21
WO2013188253A1 (en) 2013-12-19
EP2858998A4 (en) 2016-01-13
US9290509B2 (en) 2016-03-22

Similar Documents

Publication Publication Date Title
US9463448B2 (en) Diallyl ethers of anhydrohexitols and processes for making the same
KR101669297B1 (en) A process for preparing [1s-[1-alpha,2-alpha,3-beta(1s*,2r*),5-beta]]-3-[7-[2-(3,4-difluorophenyl)-cyclopropylamino]-5-(propylthio)-3h-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol and its intermediates
KR101631928B1 (en) Dianhydrosugar production process
Somfai et al. Asymmetric synthesis of (+)-1-deoxynojirimycin and (+)-castanospermine
Aoki et al. Total syntheses of natural pseurotins A, F2, and azaspirene
EP2496565B1 (en) Process for preparing divinylarene dioxides
WO2006093281A1 (en) METHOD FOR PRODUCING α-HYDROXY-ω-GLYCIDYL ETHER
Khatri et al. Fluoroalcohol-mediated reductive iodonio-Claisen rearrangement: Synthesis of complex ortho-substituted-allyl iodoarenes
EP3529230B1 (en) Synthesis of bicyclo(2.2.2)octanes
US9290509B2 (en) Monoallyl, monoglycidyl ethers and bisglycidyl ethers of isohexides
CN103864813B (en) Synthetic methods of hexahydrofuro[2,3-b]furan-3-ol and enantiomer thereof
JP2017501147A (en) Synthesis of isohexide ether and isohexide carbonate.
Sharma et al. Stereoselective total synthesis of dinemasone A by double intramolecular hetero-Michael addition (DIHMA)
US8927742B2 (en) Process for preparing Nebivolol
WO2013173020A1 (en) Isosorbide and isomannide derivatives and processes for making the same
US20160016969A1 (en) Isohexide monotriflates and process for synthesis thereof
WO2015011474A1 (en) Preparation of saturated ketone morphinan compounds by catalytic isomerisation
WO2013188005A1 (en) Monofluorinated derivatives of dianhydrohexitols and processes for making the same
US20040039209A1 (en) Compounds containing oxazolidinone moiety and uses thereof
KR20080038284A (en) Process for preparing of epichlorohydrine
CN118290433A (en) Preparation method and application of chiral dihydrofuran [3,4-b ] quinoline-1 (3H) -ketone
KR101519011B1 (en) Preparation method of pyrano coumarin derivatives catalyzed by bismuth salts
WO2014168698A1 (en) Mono-ethers of isohexides and process for making the same
CN118546149A (en) Preparation method of 5-spiro camptothecin
WO2007039493A1 (en) Efficient catalyst for the asymmetric epoxidation of electron deficient as well as non electron deficient alkenes

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20141205

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: B01J 31/02 20060101ALI20150922BHEP

Ipc: C07D 493/04 20060101ALI20150922BHEP

Ipc: C07D 307/12 20060101AFI20150922BHEP

RA4 Supplementary search report drawn up and despatched (corrected)

Effective date: 20151210

RIC1 Information provided on ipc code assigned before grant

Ipc: C07D 307/12 20060101AFI20151204BHEP

Ipc: B01J 31/02 20060101ALI20151204BHEP

Ipc: C07D 493/04 20060101ALI20151204BHEP

17Q First examination report despatched

Effective date: 20170331

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20170613